{"id":"W2800164512","doi":"10.1016/j.jaci.2018.03.011","title":"A novel human mast cell activation test for peanut allergy","year":2018,"lang":"en","type":"letter","venue":"Journal of Allergy and Clinical Immunology","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"U.S. Army Medical Research and Development Command; Canadian Institutes of Health Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Medical Research Council; Alberta Heritage Foundation for Medical Research; King's College London; European Academy of Allergy and Clinical Immunology; University of Alberta; Genome Prairie; National Peanut Board; National Institute for Health and Care Research; Genome Canada; Immune Tolerance Network; Sanofi; Menzies Centre for Australian Studies, King's College London, University of London; AstraZeneca; Asthma and Lung UK; Natural Sciences and Engineering Research Council of Canada; King's College Hospital NHS Foundation Trust; Pfizer","keywords":"Overdiagnosis; Peanut allergy; Anaphylaxis; Immunoglobulin E; Medicine; Food allergy; Gold standard (test); Allergy; Immunology; Oral immunotherapy; Oral food challenge; Mast cell; Oral allergy syndrome; Internal medicine; Antibody","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008730363,0.000388004,0.001255212,0.0004051844,0.000228607,0.0000447213,0.0004364774,0.002070755,0.0004657131],"category_scores_gemma":[0.001050961,0.0003059982,0.0007710393,0.0001338528,0.0007910611,0.0001253178,0.0001613903,0.004085028,0.00002251459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006892881,"about_ca_system_score_gemma":0.0004089375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002252004,"about_ca_topic_score_gemma":0.00005003862,"domain_scores_codex":[0.9966936,0.0001682979,0.001675942,0.0004644025,0.0004163829,0.0005814064],"domain_scores_gemma":[0.9955743,0.001657317,0.00123546,0.0004110757,0.0009492046,0.000172635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002263852,0.00165855,0.00007152808,0.0001796678,0.006390582,0.0003155834,0.00007697784,5.867599e-7,0.01351682,0.0001040577,0.9705797,0.004842065],"study_design_scores_gemma":[0.006324142,0.0162172,0.00437067,0.0003896402,0.00005313187,0.0004418169,0.00007962243,0.0000164169,0.0005137449,0.0003473531,0.9709657,0.0002805391],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.06213797,0.003759277,0.001659726,0.9214151,0.002831241,0.0008761273,0.00006215348,0.00005822226,0.007200218],"genre_scores_gemma":[0.06397458,0.03291254,0.009205462,0.7084247,0.08445847,0.00008196253,0.001239241,0.0005712576,0.09913175],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.2129903,"threshold_uncertainty_score":0.9999392,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06331845406068977,"score_gpt":0.3680004396001583,"score_spread":0.3046819855394686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}